These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8438609)

  • 1. Novel vaccination strategies for the control of mucosal infection.
    Husband AJ
    Vaccine; 1993; 11(2):107-12. PubMed ID: 8438609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants.
    Chin J; San Gil F; Novak M; Eamens G; Djordjevic S; Simecka J; Duncan J; Mullbacher A
    J Biotechnol; 1996 Jan; 44(1-3):13-9. PubMed ID: 8717381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
    Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvants on orally administered antigens.
    Genco RJ; Linzer R; Evans RT
    Ann N Y Acad Sci; 1983 Jun; 409():650-68. PubMed ID: 6347002
    [No Abstract]   [Full Text] [Related]  

  • 6. Lambda display phage as a mucosal vaccine delivery vehicle for peptide antigens.
    González-Cano P; Gamage LNA; Marciniuk K; Hayes C; Napper S; Hayes S; Griebel PJ
    Vaccine; 2017 Dec; 35(52):7256-7263. PubMed ID: 29153779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to infectious agents in the gastrointestinal tract.
    Befus AD; Bienenstock J
    J Am Vet Med Assoc; 1982 Nov; 181(10):1066-8. PubMed ID: 7174424
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
    Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
    J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery strategies to enhance oral vaccination against enteric infections.
    Davitt CJ; Lavelle EC
    Adv Drug Deliv Rev; 2015 Aug; 91():52-69. PubMed ID: 25817337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres.
    Mutwiri G; Bowersock T; Kidane A; Sanchez M; Gerdts V; Babiuk LA; Griebel P
    Vet Immunol Immunopathol; 2002 Sep; 87(3-4):269-76. PubMed ID: 12072246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired mucosal immune responses in interleukin 4-targeted mice.
    Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
    J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
    Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
    Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes of priming and challenge for IgA antibody-containing cell responses in the intestine.
    Dunkley ML; Husband AJ
    Immunol Lett; 1990 Nov; 26(2):165-70. PubMed ID: 2148544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.
    Gärdby E; Lycke NY
    Eur J Immunol; 2000 Jul; 30(7):1861-71. PubMed ID: 10940875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
    Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
    Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunity and strategies for novel microbial vaccines.
    Mestecky J; Moldoveanu Z; Novak M; Compans RW
    Acta Paediatr Jpn; 1994 Oct; 36(5):537-44. PubMed ID: 7825460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of mucosal vaccines to Peyer's patch M cells.
    Frey A; Neutra MR
    Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked Differences in Mucosal Immune Responses Induced in Ileal versus Jejunal Peyer's Patches to Mycobacterium avium subsp. paratuberculosis Secreted Proteins following Targeted Enteric Infection in Young Calves.
    Facciuolo A; Gonzalez-Cano P; Napper S; Griebel PJ; Mutharia LM
    PLoS One; 2016; 11(7):e0158747. PubMed ID: 27387969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALT: organization and dynamics leading to IgA synthesis.
    Suzuki K; Kawamoto S; Maruya M; Fagarasan S
    Adv Immunol; 2010; 107():153-85. PubMed ID: 21034974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
    Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
    J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.